MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tauopathies"

  • MDS Virtual Congress 2020

    Can we stage tau pathology in PSP?

    G. Kovacs, M. Lukic, D. Irwin, T. Arzberger, G. Respondek, E. Lee, D. Coughlin, A. Giese, M. Grossman, C. Kurz, C. McMillan, E. Gelpi, Y. Compta, J. van Swieten, C. Troakes, S. Al-Sarraj, J. Robinson, S. Roeber, S. Xie, V. Lee, J. Trojanowski, G. Höglinger (Phildelphia, PA, USA)

    Objective: To evaluate distribution pattern of tau pathology in different PSP clinical subtypes and develop a staging system. Background: Progressive supranuclear palsy (PSP) is a…
  • MDS Virtual Congress 2020

    18kDa Translocator Protein PET in 4-Repeat Tauopathies – A Cross-Sectional Single Center Study

    C. Palleis, J. Sauerbeck, L. Beyer, S. Harris, J. Schmitt, A. Finze, A. Nitschmann, G. Biechele, K. Boetzel, A. Danek, B. Rauchmann, M. Unterrainer, N. Albert, R. Rupprecht, P. Bartenstein, R. Perneczky, C. Haass, J. Levin, G. Hoeglinger, M. Brendel (Munich, Germany)

    Objective: The aim of this single center study was to analyse the potential of 18F-GE-180 TSPO PET as a biomarker in 4R-tauopathies. Background: The pathological…
  • 2019 International Congress

    Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements

    D. Coughlin, C. Petersen, R. Lobrovich, D. Wolk, A. Siderowf, D. Weintraub, E. Lee, J. Trojanowski, M. Grossman, D. Irwin (Philadelphia, PA, USA)

    Objective: To compare the regional distribution of cortical tau pathology between Lewy body disorders (LBD: Parkinson’s disease and dementia with Lewy bodies (DLB)) and progressive…
  • 2019 International Congress

    Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

    G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)

    Objective: To evaluate the frequency of prescription medications commonly associated with the management of PSP in the community. Background: Progressive Supranuclear Palsy (PSP) is a…
  • 2019 International Congress

    Skin in the game: Small fiber neuropathy in Parkinson’s disease and atypical parkinsonisms.

    R. Infante, G. Rizzo, A. Incensi, C. Scaglione, S. Capellari, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: The aim of our study was to compare somatic and autonomic small fiber density, through skin biopsy, in Parkinson's disease (PD) and atypical parkinsonisms…
  • 2019 International Congress

    Deciphering Corticobasal Syndrome: are clinical features and FDG-PET imaging capable of predicting amiloyd status?

    J. Parmera, A. Coutinho, A. Neto, M. Aranha, C. Ono, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki (São Paulo, Brazil)

    Objective: The present study aimed at establishing clinical and brain functional patterns at FDG-PET that could distinguish Corticobasal Syndrome(CBS) variants due to AD from Tau pathology based on Pittsburgh Compound…
  • 2019 International Congress

    Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

    JJ. Hu, T. Wang (Wuhan, China)

    Objective: To investigate the role and mechanism of C3a receptor in okadaic acid(OA) induced SH-SY5Y cells tau hyperphosphorylation model Background: Neurofibrillary tangles aggregated from hyperphosphorylated…
  • 2019 International Congress

    Heavy metals implicated in a geographical cluster of progressive supranuclear palsy induce tau accumulation and apoptotic cell death in cultured neurons

    C. Alquezar, J. Felix, E. Mccandlish, B. Buckley, D. Caparros-Lefebvre, C. Karch, L. Golbe, A. Kao (San Francisco, CA, USA)

    Objective: To test the hypothesis that certain metals may cause cellular damage suggesting tauopathy. This is an early step in testing the hypothesis that environmental…
  • 2019 International Congress

    Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

    N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)

    Objective: To investigate grey matter volume in typical and variant Parkinson-plus syndromes, to correlate these with disease severity, and to assess regional atrophy within disease…
  • 2019 International Congress

    Clinico-pathological Findings In Autopsy Cases With Non-Specific Glial Tauopathy

    E. Zamrini, CH. Adler, GE. Serrano, N. Zhang, DR. Shprecher, SH. Mehta, MN. Sabbagh, E. Driver-Dunckley, HA. Shill, LI. Sue, TG. Beach (Sun City, AZ, USA)

    Objective: Determine Clinico-pathological correlates of aging-related tau astrogliopathy (ARTAG). Background: Aging-related tau astrogliopathy (ARTAG) appears to be a morphological spectrum of astroglial pathology mostly seen in…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 16
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley